Moreover, it is emerging that PI3K could control other downstream targets in cancer cells, including serum/glucocorticoid-regulated kinase 3 (SGK3), in a manner which is independent from PIP3, but dependent on phosphatidylinositol 3-phosphate [53]. The gene discussed is PIK3CG; the disease is cancer.